GNRH1 and neoplasm: The cytotoxic LHRH analog completely blocked tumor growth at the end of the treatment resulting in a 90.5% inhibition compared to control and was also significantly better than [D-Lys(6)]LHRH (p<0.01) and DOX alone (p<0.05).